✦ LIBER ✦

PDB30 Assessment of the Impact of the New Antidiabetic Treatment with Vildagliptin to Change the Total Costs on Diabetes Type 2

✍ Scribed by Yanovskaya, M.Y.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB2 THE IMPACT OF ORAL ANTIDIABETICS ON

✍ D Tasic; D Brixner; M Goodman 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

PDB19 ESTIMATING THE COST EFFECTIVENESS

✍ A Brennan; M Gillett; A Duenas 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

PDB43 Economic Evaluation of Vildaglipti

✍ Hatzikou, M.; Rombopoulos, G.; Yfantopoulos, J. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PDB5 THE IMPACT OF ANTIDIABETIC-INDUCED

✍ Y. Zhao; L. Shi; V. Fonseca; C. Campbell 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

PDB18 COST OFFSETS ASSOCIATED WITH USE O

✍ MD Pawaskar; J Anderson; AJ Zagar 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

PDB39 Cost-Effectiveness of Saxagliptin

✍ Hutchings, A.; Tolley, K.; Achana, F.; Brereton, N.J.; Lebmeier, M.; Mesa, O.A. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB